Protective effect of simvastatin on induced diabetic retinopathy and endothelial progenitor cells in adult male albino rat, histological and immunohistochemical study | ||||
| The Egyptian Journal of Anatomy | ||||
| Article 12, Volume 40, Issue 1, January 2017, Page 173-188 PDF (2.12 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejana.2017.5721 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Eman Sadek; Lamiaa Abd El Fattah; Zeinab El Maadawi; Manal Abd-El Mohsen | ||||
| Department of Histology, Faculty of Medicine,Cairo University | ||||
| Abstract | ||||
| Background and Objectives: Diabetic retinopathy (DR) is one of the main causes of blindness and there is no available treatment for complete cure. This study was planned to evaluate the potential protective effects of simvastatin in a rat model of DR with special emphasis on endothelial progenitor cells (EPCs). Methods: Thirty adult male albino rats were equally divided into: Group І (control group), Group II (diabetic group) and Group III (diabetic/simvastatin treated group). Diabetes was induced by intraperitoneal injection of streptozotocin (STZ) 50 mg/Kg /rat in 20 adult male albino rats. Simvastatin was administered as 20 mg/Kg/rat 48 hours after STZ injection via oral route. Body weight and blood glucose levels were measured weekly for 1 month. Flowcytometry was used to detect circulating endothelial progenitor cells (EPCs). Retinal specimens were processed for hematoxylin and eosin staining as well as CD31 and caspase 3 immunohistochemistry. Morphometric analysis included measurement of retinal thickness, number of ganglion cells, number of CD31 positive cells and area percent of caspase 3 positive immunereaction. All results were statistically analyzed. Results: Flowcytometry showed that simvastatin was able to increase the percentage of circulating EPCs in group III compared to group II. Group II showed histological features of DR, CD 31 immuno-reaction was comparable to control and caspase 3 immuno-reaction increased significantly compared to control. Group III showed improved features of DR, significant increase in CD 31 and decrease in caspase 3 immuno-reactivity. Conclusions: These results suggest that simvastatin has protective effects on DR and might be considered as promising therapeutic agent for it. | ||||
| Keywords | ||||
| diabetic retinopathy; endothelial progenitor cells– statins; STZ | ||||
|
Statistics Article View: 238 PDF Download: 353 |
||||
